Navigation Links
Hormonal Disorder Linked to Pregnancy Complications: Study
Date:10/14/2011

FRIDAY, Oct. 14 (HealthDay News) -- A common hormonal disorder among women known as polycystic ovary syndrome (PCOS) seems to be associated with an increased risk for pregnancy complications, such as preeclampsia, diabetes and premature birth, a new study indicates.

PCOS affects between 5 percent and 15 percent of women of reproductive age, according to background information in the study published in the Oct. 13 online edition of BMJ. Symptoms include irregular periods, ovulation problems, weight gain and excessive hair growth, and women with the disorder typically have small cysts on their ovaries.

In the study, Swedish researchers compared just under 3,800 births among women with PCOS with nearly 1.2 million births among women without the condition, and found that women with PCOS were more likely to be obese and to use assisted reproductive technology.

Women with PCOS were 45 percent more likely to experience preeclampsia (a condition that causes high blood pressure in pregnant women) and more than twice as likely to develop diabetes during pregnancy and/or to give birth prematurely, compared to women without PCOS, the investigators found.

In addition, babies born to women with PCOS were more likely to be large for gestational age and tended to develop asphyxia (a lack of oxygen) during labor, according to Nathalie Roos and colleagues at the Karolinska Institute and Karolinska University Hospital in Stockholm.

The increased risk of pregnancy complications among women with PCOS could not be attributed to advanced age, being overweight or obese, or the use of assisted reproductive technology, the researchers pointed out in a journal news release.

"These women may need increased surveillance during pregnancy and childbirth. Future research would benefit from focusing on glucose control, medical treatment and hormonal status among women with polycystic ovary syndrome during pregnancy," the researchers concluded.

"It is clear that women with polycystic ovary syndrome should be considered 'high risk' obstetric patients and that midwives, general practitioners and obstetricians should monitor these women as such," Nick Macklon, of the University of Southampton in England, wrote in an accompanying editorial.

However, "more evidence is required to support the use of currently used interventions designed to reduce perinatal risk, and this requires a greater understanding of the different polycystic ovary syndrome phenotypes and the underlying mechanisms by which this common condition alters pregnancy outcomes," Macklon added.

More information

The U.S. National Institute of Child Health and Human Development has more about polycystic ovary syndrome.

-- Robert Preidt

SOURCE: BMJ, news release, Oct. 13, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Fewer than half of breast cancer patients adhere to hormonal therapy regimen, study finds
2. Side effects of hormonal breast cancer therapy increased; may affect treatment adherence
3. New hope for advanced post-menopausal breast cancer patients resistant to hormonal therapy
4. UH researchers explain hormonal role in glucose and fat metabolism
5. People with anxiety disorder less able to regulate response to negative emotions, study shows
6. NIH grants to Childrens Hospital will advance novel stem cell treatments for blood disorders
7. Tennessee Orofacial Myology, LLC is the First Office to Open in Tennessee to Help Patients with Orofacial Disorders
8. Anxiety Disorder Patients Process Emotions Differently
9. Figure Skating Standards Foster Eating Disorders, Says Kimberly Dennis, M.D.
10. Remuda Ranch Programs for Eating and Anxiety Disorders Sponsors a Special Edition of the Award-Winning Documentary America The Beautiful
11. Visual Cues that Improve Walking for People with Movement Disorders - Study Shows Small Change in Arrangement Can Make a Big Difference in Improvement Gained
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hormonal Disorder Linked to Pregnancy Complications: Study
(Date:4/26/2017)... ... April 26, 2017 , ... Datos Health , developer of ... Med-e-Mass , the largest Electronic Medical Records (EMR) provider in South Africa. ... incentives to a patient’s remote health progress, empowering the patient to take direct responsibility ...
(Date:4/26/2017)... ... ... Infertility may be a result of an underlying pelvic ... become pregnant upon treating their diagnosis. , To properly diagnose patients, ... can provide the necessary information to diagnose and treat your problem. , ...
(Date:4/26/2017)... ... April 26, 2017 , ... Want to learn ... ( CRISPRCas.pioneer.com ) that demonstrates how this advanced plant breeding technology is a ... food, with fewer resources. It highlights the business’ principles, research and collaboration efforts ...
(Date:4/26/2017)... ... April 26, 2017 , ... MYOLYN, a ... announce that it has received 510(k) clearance from the U.S. Food & Drug ... MyoCycle Pro. , Both devices are stationary cycling systems that use MYOLYN’s patent-pending ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... they have signed an agreement to be the preferred physical therapy provider for ... and returning them to Derby City CrossFit as quickly and effectively as possible, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment is ... period The Cardiology Devices segment is likely to ... 15 Mn in 2018 over 2017. By the end of ... valuation close to US$ 700 Mn, expanding at a CAGR ... dominated the Asia Pacific reprocessed medical ...
Breaking Medicine Technology: